Atg5, whose activity is enhanced by UroA, plays a role in the final step of autophagy, specifically in the fusion of the autophagosome and the lysosome
Understanding this decline helps explain why recovery and tissue integrity change over time
MarMMoralesAColellAGarca-RuizCFernndez-ChecaJC
Researchers identified a hit, a drug that was developed nearly a decade ago
Important caveat: injectable and IV NAD+ are not FDA-approved (nor approved by any major regulator) for energy, metabolic or longevity uses, and their safety and efficacy for these marketed uses are not established
[1] It is investigated for its potential role in nitric oxide pathway modulation, growth factor signaling, and extracellular matrix remodeling